Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug utilization research in Peru: Is real-world data available?
Rodríguez-Tanta LY, Garavito Farro H, Freitas Leal L, Salas M, Elseviers MM, Lopes LC. Rodríguez-Tanta LY, et al. Among authors: salas m. Front Pharmacol. 2023 Jan 17;13:1047946. doi: 10.3389/fphar.2022.1047946. eCollection 2022. Front Pharmacol. 2023. PMID: 36733379 Free PMC article.
Challenges facing drug utilization research in the Latin American region.
Salas M, Lopes LC, Godman B, Truter I, Hartzema AG, Wettermark B, Fadare J, Burger JR, Appenteng K, Donneyong M, Arias A, Ankrah D, Ogunleye OO, Lubbe M, Horne L, Bernet J, Gómez-Galicia DL, Del Carmen Garcia Estrada M, Oluka MN, Massele A, Alesso L, Herrera Comoglio R, da Costa Lima E, Vilaseca C, Bergman U. Salas M, et al. Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1353-1363. doi: 10.1002/pds.4989. Epub 2020 May 17. Pharmacoepidemiol Drug Saf. 2020. PMID: 32419226 Free article. Review.
Data sources for drug utilization research in Latin American countries-A cross-national study: DASDUR-LATAM study.
Lopes LC, Salas M, Osorio-de-Castro CGS, Leal LF, Doubova SV, Cañás M, Dreser A, Acosta A, Baldoni AO, de Cássia Bergamaschi C, Mota DM, Gómez-Galicia DL, Sepúlveda-Viveros D, Delgado EN, da Costa Lima E, Chandia FV, Ferre F, Marin GH, Olmos I, Zimmermann IR, Fulone I, Roldán-Saelzer J, Sánchez-Salgado JC, Castro-Pastrana LI, de Souza LJC, Beltrán MM, Silva MT, Mena MB, de França Fonteles MM, Urtasun MA, Tarapués M, Hernández PG, Medero N, Herrera-Comoglio R, Barberato-Filho S, Galvão TF, Luiza VL, Santa-Ana-Tellez Y, Rodríguez-Tanta Y, Elseviers M. Lopes LC, et al. Among authors: salas m. Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):343-352. doi: 10.1002/pds.5404. Epub 2022 Jan 13. Pharmacoepidemiol Drug Saf. 2022. PMID: 34957616
Discrepancies in ICD-9/ICD-10-based codes used to identify three common diseases in cancer patients in real-world settings and their implications for disease classification in breast cancer patients and patients without cancer: a literature review and descriptive study.
Tu N, Henderson M, Sundararajan M, Salas M. Tu N, et al. Among authors: salas m. Front Oncol. 2023 Sep 6;13:1016389. doi: 10.3389/fonc.2023.1016389. eCollection 2023. Front Oncol. 2023. PMID: 37746274 Free PMC article.
1,239 results